GlassScriptPhysician profile
Robert Yong
NPI 1205002144
$231,420.69
in general payments reported to CMS, 2019-2025
27 companies · $34K in 2025
The $34K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $20K · 2021: $23K · 2022: $33K · 2023: $52K · 2024: $51K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $74K · Consulting Fee: $27K · Food and Beverage: $13K · Travel and Lodging: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,766 · Honoraria: $1,200 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $74,470.00 |
| Consulting Fee | $26,615.00 |
| Food and Beverage | $13,201.69 |
| Travel and Lodging | $11,320.33 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,766.15 |
| Honoraria | $1,200.00 |
| Education | $108.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $117,009.01 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Vanta Adaptivestim |
| Medtronic USA, INC. | $26,574.37 | 2019-2020 | |
| Abbott Laboratories | $20,727.00 | 2019-2025 | Proclaim, Eterna, Axium |
| Nevro Corp. | $20,123.73 | 2019-2024 | Senza |
| Boston Scientific Corporation | $12,616.72 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, Intracept |
| Biotronik Nro, INC. | $11,989.63 | 2024-2025 | Prospera |
| Abbvie INC. | $10,028.52 | 2022-2025 | |
| Brixton Biosciences, INC. | $7,265.41 | 2024-2025 | Neural Ice |
| Stratus Medical, LLC | $1,177.38 | 2025 | Nimbus |
| Saluda Medical Americas, INC. | $1,013.44 | 2023-2025 | Evoke, Evoke Scs |
| Vertos Medical, INC. | $616.73 | 2022-2024 | Mild Device Kit |
| Mml US, INC. | $403.63 | 2022-2025 | Reactiv8 |
| Vertex Pharmaceuticals Incorporated | $386.10 | 2024-2025 | |
| Globus Medical, INC. | $236.16 | 2025 | Senza |
| Painteq LLC | $188.10 | 2021-2024 | Painteq |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $160.19 | 2025 | Sprint Pns System |
| Stryker Corporation | $145.69 | 2020-2025 | Spinejack, Mild Device Kit |
| Curonix LLC | $141.76 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $121.00 | 2019-2020 | |
| Bioventus LLC | $116.64 | 2023-2025 | Durolane, Stimrouter Implantable Kit, Xcell |
| Depuy Synthes Sales INC. | $99.36 | 2019 | |
| Siemens Medical Solutions USA, INC. | $92.95 | 2023 | |
| Si-Bone, INC. | $80.97 | 2019-2024 | |
| Relievant Medsystems, INC. | $33.53 | 2023 | Intracept |
| Averitas Pharma INC. | $33.32 | 2024 | Qutenza |
| Nalu Medical, INC. | $25.98 | 2025 | Nalu Neurostimulation System |
| Tempus Ai, INC | $13.37 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Yong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.